Medicare Program; Quality Incentive Program; Correction, 13251-13252 [2015-05766]
Download as PDF
Federal Register / Vol. 80, No. 49 / Friday, March 13, 2015 / Rules and Regulations
Dated: February 19, 2015.
Nanci E. Gelb,
Acting Assistant Administrator, Office of
Administration and Resources Management.
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 22
[EPA–HQ–OECA–2014–0551; FRL–9922–
62–OECA]
Accordingly, 40 CFR part 22 is
corrected by making the following
correcting amendment:
Consolidated Rules of Practice
Governing the Administrative
Assessment of Civil Penalties,
Issuance of Compliance or Corrective
Action Orders, and the Revocation,
Termination or Suspension of Permits;
Correction
PART 22—CONSOLIDATED RULES OF
PRACTICE GOVERNING THE
ADMINISTRATIVE ASSESSMENT OF
CIVIL PENALTIES AND THE
REVOCATION, TERMINATION OR
SUSPENSION OF PERMITS
Environmental Protection
Agency.
ACTION: Correcting amendment.
AGENCY:
1. The authority citation for part 22
continues to read as follows:
■
The Environmental Protection
Agency (EPA) published a document in
the Federal Register on November 6,
2014. That document included the
correct mailing and hand delivery
addresses for the Environmental
Appeals Board, but inadvertently failed
to omit the incorrect addresses. This
amendment deletes the incorrect
addresses.
DATES: Effective on March 13, 2015.
FOR FURTHER INFORMATION CONTACT:
Ammie Roseman-Orr, Environmental
Appeals Board, U.S. Environmental
Protection Agency, William Jefferson
Clinton Building East, Room 3332, 1200
Pennsylvania Ave. NW., Mail Code
1103M, Washington DC 20460, phone
number (202) 233–0122 or by email at
roseman-orr.ammie@epa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background
The rule amendment published on
November 6, 2014 (79 FR 65897),
corrected the mailing and hand delivery
addresses for the Environmental
Appeals Board in § 22.5(a) to reflect the
Board’s relocation. The rule also revised
§ 22.30(a)(1) by adding a reference to the
corrected addresses in § 22.5(a). This
amendment, however, inadvertently did
not omit the Board’s incorrect addresses
in the second and third sentences of
§ 22.30(a)(1).
tkelley on DSK3SPTVN1PROD with RULES
Need for Correction
As published on November 6, 2014
(79 FR 65897), the final regulation
contains an error which may prove to be
misleading and is in need of
clarification.
List of Subjects in 40 CFR Part 22
Environmental protection,
Administrative practice and procedure,
Air pollution control, Hazardous
substances, Hazardous waste, Penalties,
Pesticides and pests, Poison prevention,
Water pollution control.
VerDate Sep<11>2014
16:34 Mar 12, 2015
Jkt 235001
Authority: 7 U.S.C. 136(l); 15 U.S.C. 2615;
33 U.S.C. 1319, 1342, 1361, 1415 and 1418;
42 U.S.C. 300g–3(g), 6912, 6925, 6928, 6991e
and 6992d; 42 U.S.C. 7413(d), 7524(c),
7545(d), 7547, 7601 and 7607(a), 9609, and
11045.
§ 22.30
[Corrected]
2. In § 22.30, paragraph (a)(1) is
amended by removing the second and
third sentences.
■
[FR Doc. 2015–05438 Filed 3–12–15; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 405, 411, 413 and 414
[CMS–1614–CN]
RIN 0938–AS13
Medicare Program; Quality Incentive
Program; Correction
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final rule; correction.
AGENCY:
This document corrects
technical errors that appeared in the
final rule published in the Federal
Register on November 6, 2014 entitled
‘‘End-Stage Renal Disease Prospective
Payment System, Quality Incentive
Program, and Durable Medical
Equipment, Prosthetics, Orthotics, and
Supplies.’’
SUMMARY:
This correction is effective on
March 13, 2015.
FOR FURTHER INFORMATION CONTACT:
Tamyra Garcia, (410) 786–0856.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background
In FR Doc. 2014–26182 of November
6, 2014 (79 FR 66120), there were
technical and typographical errors that
PO 00000
Frm 00053
Fmt 4700
Sfmt 4700
13251
are identified and corrected in the
Correction of Errors section below. The
provisions in this correction document
are effective as if they had been
included in the document published on
November 6, 2014. Accordingly, the
corrections are effective March 13, 2015.
II. Summary of Errors
On page 66184 of the preamble, we
have determined that there were errors
in the performance standard,
achievement threshold, and benchmark
values presented in the Numerical
Values for the Performance Standards
for the Payment Year (PY) 2017 EndStage Renal Disease (ESRD) Quality
Incentive Program (QIP) Clinical
Measures Using the Most Recently
Available Data table for PY 2017 of the
ESRD QIP (Table 23). Specifically, the
numerical values published for the
Standardized Readmission Ratio clinical
measure were calculated using only 6
months of data from calendar year 2013
instead of the full 12 months, as
specified under our finalized policy (79
FR 66183). Therefore, we are publishing
this technical correction to ensure that
these numerical standards align with
the finalized policies for the PY 2017
ESRD QIP.
III. Waiver of Proposed Rulemaking
We ordinarily publish a notice of
proposed rulemaking in the Federal
Register to provide a period for public
comment before the provisions of a rule
take effect in accordance with section
553(b) of the Administrative Procedure
Act (APA) (5 U.S.C. 553(b)). However,
we can waive this notice and comment
procedure if the Secretary finds, for
good cause, that the notice and
comment process is impracticable,
unnecessary, or contrary to the public
interest, and incorporates a statement of
the finding and the reasons; therefore, in
the notice.
Since this rule correction is simply
correcting technical and typographical
errors in the preamble, but does not
make substantive changes to the policies
or payment methodologies that were
adopted in the final rule, it is
unnecessary to follow the notice and
comment procedure in this instance.
Therefore, we believe that we have good
cause to forego notice and a period for
comment.
IV. Correction of Errors
In FR Doc. 2014–26182 of November
6, 2014 (79 FR 66120) make the
following corrections:
1. On page 66184, in Table 23
‘‘Numerical Values for the Performance
Standards for the PY 2017 ESRD QIP
Clinical Measures Using the Most
E:\FR\FM\13MRR1.SGM
13MRR1
13252
Federal Register / Vol. 80, No. 49 / Friday, March 13, 2015 / Rules and Regulations
Recently Available Data’’; in the fifth
row titled ‘‘Standardized Readmission
Ratio’’ remove the existing values and
add the following values in their place:
Measure
Performance
standard
Achievement
threshold
Benchmark
Standardized Readmission Ratio ................................................................................................
0.648
1.261
0.998
Dated: March 6, 2015.
C’Reda Weeden,
Executive Secretary to the Department,
Department of Health and Human Services.
describes the Department’s symbol, seal,
and logo.
[FR Doc. 2015–05766 Filed 3–12–15; 8:45 am]
This rule does not meet the criteria for
a significant regulatory action under
Executive Order 12866. Thus, review by
the Office of Management and Budget is
not required.
Regulatory Flexibility Act
45 CFR Part 18
This rule will not have a significant
economic impact on a substantial
number of small entities. Therefore, a
regulatory flexibility analysis as
provided by the Regulatory Flexibility
Act, as amended, is not required.
Official Symbol, Logo and Seal
Office of the Secretary, HHS.
Final rule.
AGENCY:
ACTION:
The U.S. Department of
Health and Human Services (HHS) is
adopting final regulations containing a
description of its official symbol, logo,
and seal.
DATES: This rule is effective April 13,
2015 without further action.
FOR FURTHER INFORMATION CONTACT:
Gloria Barnes, Office of the Assistant
Secretary for Public Affairs
(gloria.barnes@hhs.gov).
SUPPLEMENTARY INFORMATION: HHS is
adopting regulations (45 CFR part 18)
describing its official logo and seal. HHS
has developed a symbol, logo, and seal
that signifies the authoritativeness of the
item or document to which it is affixed
as an official endorsement of HHS.
Pursuant to 5 U.S.C. 553(b)(A), notice
and comment are not required because
this rule only impacts HHS’ procedure
and practice. In addition, pursuant to 5
U.S.C. 553(b)(B), there is good cause to
waive notice and comment as
unnecessary, because this rule is noncontroversial and merely describes
HHS’ official symbol, logo, and seal.
HHS previously published a Direct
Final Rule on April 14, 2014 (79 FR
20801). In response, HHS received two
public comments. Among other things,
both comments argued that the rule
violated the First Amendment. The
commenters argued that restrictions in
the Direct Final Rule violated the First
Amendment by not including
exceptions for certain uses of the seal
(e.g., for illustrative purposes by the
media). HHS withdrew this rule on June
4, 2014 (79 FR 32170). HHS is now
publishing a Final Rule that merely
tkelley on DSK3SPTVN1PROD with RULES
SUMMARY:
VerDate Sep<11>2014
16:34 Mar 12, 2015
Jkt 235001
Paperwork Reduction Act
This rule does not contain any
collections of information subject to the
Paperwork Reduction Act.
List of Subjects in 45 CFR Part 18
Seals and insignia.
For the reasons set out in the
preamble, HHS adds Part 18 to Title 45,
Subtitle A, subchapter A of the Code of
Federal Regulations as follows:
Subtitle A—DEPARTMENT OF HEALTH
AND HUMAN SERVICES
Subchapter A—GENERAL
ADMINISTRATION
PART 18—OFFICIAL SYMBOL, LOGO,
AND SEAL
Sec.
18.1
(c) The HHS Departmental Logo
(Logo) incorporates the Symbol and is
described as follows: From the tip of the
outstretched wing of the American Eagle
in symbol to the tip of the other,
downward-facing wing, the words,
‘‘DEPARTMENT OF HEALTH &
HUMAN SERVICES • USA’’ form a
circular arc. The official colors of the
Logo are either Black or Reflex Blue.
Reflex Blue RGB Numbers: 0/0/153 (R0,
G0, B153)
Description of the Symbol, Logo, and
Seal.
Authority: 42 U.S.C. 3505 and 5 U.S.C.
301.
§ 18.1 Description of the Symbol, Logo,
and Seal.
(a) The Departmental Symbol
(Symbol) of the Department of Health
and Human Services (HHS) is the key
element in Department identification. It
represents the American People
sheltered in the wing of the American
Eagle, suggesting the Department’s
concern and responsibility for the
welfare of the people. This Symbol is
the visual link which connects the
graphic communications of all
components and programs of the
Department. It is the major design
component for the Department
PO 00000
Frm 00054
Fmt 4700
Sfmt 4700
(d) The HHS Departmental Seal (Seal)
incorporates the Symbol and is
described as follows: Starting from the
tip of the downward-facing wing of the
American Eagle in the HHS symbol and
forming a complete circle clockwise
around the HHS symbol, the words,
‘‘DEPARTMENT OF HEALTH &
HUMAN SERVICES • USA •’’ are
printed, surrounded by a border
composed of a solid inner ring at the
base of the text and a triangular,
scalloped edge at the top of the text. The
E:\FR\FM\13MRR1.SGM
13MRR1
ER13MR15.003
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ER13MR15.002
BILLING CODE 4120–01–P
Executive Order No. 12866
Identifiers — the Department Logo, Seal,
and Signatures.
(b) The Symbol is described as
follows: The outline of an American
Eagle, facing left, with one of its wings
stretched upward and the other wing
pointed downward, is flanked on its
right side by two outlines of the profile
of a human head, both of which are
located in between the eagle’s wings.
One of the profile outlines is smaller
than the other and is nestled in the
larger outline.
Agencies
[Federal Register Volume 80, Number 49 (Friday, March 13, 2015)]
[Rules and Regulations]
[Pages 13251-13252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-05766]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 405, 411, 413 and 414
[CMS-1614-CN]
RIN 0938-AS13
Medicare Program; Quality Incentive Program; Correction
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: This document corrects technical errors that appeared in the
final rule published in the Federal Register on November 6, 2014
entitled ``End-Stage Renal Disease Prospective Payment System, Quality
Incentive Program, and Durable Medical Equipment, Prosthetics,
Orthotics, and Supplies.''
DATES: This correction is effective on March 13, 2015.
FOR FURTHER INFORMATION CONTACT: Tamyra Garcia, (410) 786-0856.
SUPPLEMENTARY INFORMATION:
I. Background
In FR Doc. 2014-26182 of November 6, 2014 (79 FR 66120), there were
technical and typographical errors that are identified and corrected in
the Correction of Errors section below. The provisions in this
correction document are effective as if they had been included in the
document published on November 6, 2014. Accordingly, the corrections
are effective March 13, 2015.
II. Summary of Errors
On page 66184 of the preamble, we have determined that there were
errors in the performance standard, achievement threshold, and
benchmark values presented in the Numerical Values for the Performance
Standards for the Payment Year (PY) 2017 End-Stage Renal Disease (ESRD)
Quality Incentive Program (QIP) Clinical Measures Using the Most
Recently Available Data table for PY 2017 of the ESRD QIP (Table 23).
Specifically, the numerical values published for the Standardized
Readmission Ratio clinical measure were calculated using only 6 months
of data from calendar year 2013 instead of the full 12 months, as
specified under our finalized policy (79 FR 66183). Therefore, we are
publishing this technical correction to ensure that these numerical
standards align with the finalized policies for the PY 2017 ESRD QIP.
III. Waiver of Proposed Rulemaking
We ordinarily publish a notice of proposed rulemaking in the
Federal Register to provide a period for public comment before the
provisions of a rule take effect in accordance with section 553(b) of
the Administrative Procedure Act (APA) (5 U.S.C. 553(b)). However, we
can waive this notice and comment procedure if the Secretary finds, for
good cause, that the notice and comment process is impracticable,
unnecessary, or contrary to the public interest, and incorporates a
statement of the finding and the reasons; therefore, in the notice.
Since this rule correction is simply correcting technical and
typographical errors in the preamble, but does not make substantive
changes to the policies or payment methodologies that were adopted in
the final rule, it is unnecessary to follow the notice and comment
procedure in this instance. Therefore, we believe that we have good
cause to forego notice and a period for comment.
IV. Correction of Errors
In FR Doc. 2014-26182 of November 6, 2014 (79 FR 66120) make the
following corrections:
1. On page 66184, in Table 23 ``Numerical Values for the
Performance Standards for the PY 2017 ESRD QIP Clinical Measures Using
the Most
[[Page 13252]]
Recently Available Data''; in the fifth row titled ``Standardized
Readmission Ratio'' remove the existing values and add the following
values in their place:
----------------------------------------------------------------------------------------------------------------
Performance Achievement
Measure standard threshold Benchmark
----------------------------------------------------------------------------------------------------------------
Standardized Readmission Ratio............................... 0.648 1.261 0.998
----------------------------------------------------------------------------------------------------------------
Dated: March 6, 2015.
C'Reda Weeden,
Executive Secretary to the Department, Department of Health and Human
Services.
[FR Doc. 2015-05766 Filed 3-12-15; 8:45 am]
BILLING CODE 4120-01-P